Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 1
2003 1
2004 3
2005 1
2006 4
2007 7
2008 4
2009 10
2010 5
2011 8
2012 10
2013 8
2014 10
2015 12
2016 8
2017 5
2018 5
2019 8
2020 12
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

110 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
Humby F, Durez P, Buch MH, Lewis MJ, Rizvi H, Rivellese F, Nerviani A, Giorli G, Mahto A, Montecucco C, Lauwerys B, Ng N, Ho P, Bombardieri M, Romão VC, Verschueren P, Kelly S, Sainaghi PP, Gendi N, Dasgupta B, Cauli A, Reynolds P, Cañete JD, Moots R, Taylor PC, Edwards CJ, Isaacs J, Sasieni P, Choy E, Pitzalis C; R4RA collaborative group. Humby F, et al. Among authors: verschueren p. Lancet. 2021 Jan 23;397(10271):305-317. doi: 10.1016/S0140-6736(20)32341-2. Lancet. 2021. PMID: 33485455 Free PMC article. Clinical Trial.
Subcutaneous Sarilumab in Patients With Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open-Label Extension of a Randomized Clinical Trial.
Emery P, van Hoogstraten H, Thangavelu K, Mangan E, St John G, Verschueren P. Emery P, et al. Among authors: verschueren p. ACR Open Rheumatol. 2020 Nov;2(11):672-680. doi: 10.1002/acr2.11188. Epub 2020 Nov 8. ACR Open Rheumatol. 2020. PMID: 33164349 Free PMC article.
Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.
Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R. Verschueren P, et al. Ann Rheum Dis. 2017 Mar;76(3):511-520. doi: 10.1136/annrheumdis-2016-209212. Epub 2016 Jul 18. Ann Rheum Dis. 2017. PMID: 27432356 Clinical Trial.
The use of glucocorticoids in early rheumatoid arthritis.
Verschueren P, Westhovens R. Verschueren P, et al. Rheumatology (Oxford). 2018 Aug 1;57(8):1316-1317. doi: 10.1093/rheumatology/kex271. Rheumatology (Oxford). 2018. PMID: 28968687 Review. No abstract available.
A systematic review on the effect of DMARDs on fertility in rheumatoid arthritis.
De Cock D, Brants L, Soenen I, Pazmino S, Bertrand D, Stouten V, Westhovens R, Verschueren P. De Cock D, et al. Among authors: verschueren p. Semin Arthritis Rheum. 2020 Oct;50(5):873-878. doi: 10.1016/j.semarthrit.2020.07.003. Epub 2020 Aug 30. Semin Arthritis Rheum. 2020. PMID: 32896703 Review.
Fulminant macrophage activation syndrome in a patient with anti-synthetase syndrome.
Vulsteke F, Vulsteke JB, Balthazar T, Verbrugge FH, Dierickx D, Lenaerts J, Verschueren P, De Langhe E. Vulsteke F, et al. Among authors: verschueren p. Rheumatology (Oxford). 2020 Jul 1;59(7):1775-1777. doi: 10.1093/rheumatology/kez563. Rheumatology (Oxford). 2020. PMID: 31774540 No abstract available.
110 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page